Novel postremission strategies in adults with acute myeloid leukemiaLANCET, Jeffrey E; KARP, Judith E.Current opinion in hematology. 2009, Vol 16, Num 2, pp 105-111, issn 1065-6251, 7 p.Article

Farnesyl transferase inhibitors in myeloid malignanciesLANCET, Jeffrey E; KARP, Judith E.Blood reviews. 2003, Vol 17, Num 3, pp 123-129, issn 0268-960X, 7 p.Article

Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignanciesKARP, Judith E.Seminars in hematology. 2001, Vol 38, Num 3, pp 16-23, issn 0037-1963, SUP7Conference Paper

Farnesyltransferase inhibitors in hematologic malignancies: new horizons in therapyLANCET, Jeffrey E; KARP, Judith E.Blood. 2003, Vol 102, Num 12, pp 3880-3889, issn 0006-4971, 10 p.Article

Overcoming drug resistance: targeting more than one siteKARP, Judith E; MOOKERJEE, Bijoyesh P.Leukemia research. 2002, Vol 26, Num 1, pp 107-109, issn 0145-2126Article

Effective Chemotherapy of Acute Myelocytic Leukemia Occurring After Alkylating Agent or Radiation Therapy for Prior MalignancyVAUGHAN, William P; KARP, Judith E; BURKE, Philip J et al.VAUGHAN, William P; KARP, Judith E; Journal of clinical oncology. 2008, Vol 26, Num 21, issn 0732-183X, C165-C168, 3475-3477Article

The impact of biology on the treatment of secondary AMLGOJO, Ivana; KARP, Judith E.Cancer treatment and research. 2001, Vol 108, pp 231-255, issn 0927-3042Article

Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity : Role in Kaposi's sarcoma inflammation?SAMANIEGO, Felipe; PATI, Shibani; KARP, Judith E et al.Journal of the National Cancer Institute. Monographs. 2000, Num 28, pp 15-23, issn 1052-6773Conference Paper

Effects of Selective Checkpoint Kinase 1 Inhibition on Cytarabine Cytotoxicity in Acute Myelogenous Leukemia Cells In VitroSCHENK, Erin L; KOH, Brian D; FLATTEN, Karen S et al.Clinical cancer research (Print). 2012, Vol 18, Num 19, pp 5364-5373, issn 1078-0432, 10 p.Article

Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemiasZEIDAN, Amer M; RICKLIS, Rebecca M; GLADSTONE, Douglas E et al.British journal of haematology. 2012, Vol 158, Num 2, pp 198-207, issn 0007-1048, 10 p.Article

Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cellsKANAKRY, Christopher G; HESS, Allan D; KARP, Judith E et al.Blood. 2011, Vol 117, Num 2, pp 608-617, issn 0006-4971, 10 p.Article

A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical responsePRATZ, Keith W; CORTES, Jorge; KARP, Judith E et al.Blood. 2009, Vol 113, Num 17, pp 3938-3946, issn 0006-4971, 9 p.Article

Regulation of leukemic cell adhesion, proliferation, and survival by β-cateninEUN JOO CHUNG; HWANG, Sang-Gu; LEE, Su-Jae et al.Blood. 2002, Vol 100, Num 3, pp 982-990, issn 0006-4971Article

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndromeWECHSLER, Joshua; GREENE, Marianne; MCDEVITT, Michael A et al.Nature genetics. 2002, Vol 32, Num 1, pp 148-152, issn 1061-4036, 5 p.Article

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias : a phase 1 clinical-laboratory correlative trialKARP, Judith E; LANCET, Jeffrey E; ANGE, Dawn et al.Blood. 2001, Vol 97, Num 11, pp 3361-3369, issn 0006-4971Article

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemiaKARP, Judith E; GARRETT-MAYER, Elizabeth; LEVIS, Mark J et al.Haematologica (Roma). 2012, Vol 97, Num 11, pp 1736-1742, issn 0390-6078, 7 p.Article

A rapid and sensitive method for determination of veliparib (ABT-888), in human plasma, bone marrow cells and supernatant by using LC/MS/MSREINHARDT, Sarah; MING ZHAO; MNATSAKANYAN, Aleksander et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 52, Num 1, pp 122-128, issn 0731-7085, 7 p.Article

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasmsGORE, Steven D; BAYLIN, Stephen; RUDEK, Michelle A et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6361-6369, issn 0008-5472, 9 p.Article

Plasma inhibitory activity (PIA) : a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitorsLEVIS, Mark; BROWN, Patrick; KANTARJIAN, Hagop et al.Blood. 2006, Vol 108, Num 10, pp 3477-3483, issn 0006-4971, 7 p.Article

Phase I and pharmacologic study of infusional topotecan and carboplatin in relapsed and refractory acute leukemiaKAUFMANN, Scott H; KARP, Judith E; LITZOW, Mark R et al.Clinical cancer research. 2005, Vol 11, Num 18, pp 6641-6649, issn 1078-0432, 9 p.Article

Phase I and pharmacokinetic study of flavopiridol followed by 1-β-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemiasKARP, Judith E; PASSANITI, Antonino; TIDWELL, Michael L et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8403-8412, issn 1078-0432, 10 p.Article

Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposideBOLANOS-MEADE, Javier; KARP, Judith E; GUO, Chuanfa et al.Leukemia research. 2003, Vol 27, Num 4, pp 313-321, issn 0145-2126, 9 p.Article

Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cellsEMADI, Ashkan; LE, Anne; HARWOOD, Cynthia J et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 23, pp 7057-7062, issn 0968-0896, 6 p.Article

Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemiaKAUFMANN, Scott H; KARP, Judith E; MAURER, Matthew J et al.Haematologica (Roma). 2011, Vol 96, Num 11, pp 1619-1626, issn 0390-6078, 8 p.Article

Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitroWAHNER HENDRICKSON, Andrea E; HALUSKA, Paul; CARBONI, Joan M et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7635-7643, issn 0008-5472, 9 p.Article